Given Imaging faces setback with NSE letter from FDA

02/19/2008 | Globes (Israel) · CNNMoney

The FDA issued a "not substantially equivalent" letter to Israel-based Given Imaging Ltd. for its PillCam Colon video capsule, which features a small video camera used to spot gastrointestinal disorders. "While we are disappointed by the FDA's decision, we are evaluating our options to bring PillCam Colon to the U.S. market as quickly as possible," the company's president and CEO said.

View Full Article in:

Globes (Israel) · CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI